Zivo Bioscience, Inc.
ZIVO
$17.21
-$0.30-1.71%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.21M | -1.60M | -2.27M | -8.24M | -1.28M |
| Total Depreciation and Amortization | -- | 98.30K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.12M | 669.10K | 1.09M | 7.58M | 136.70K |
| Change in Net Operating Assets | -342.70K | -71.70K | 90.80K | 37.70K | -557.30K |
| Cash from Operations | -1.43M | -905.70K | -1.09M | -623.70K | -1.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 488.20K | 0.00 | 0.00 | 0.00 | 517.60K |
| Total Debt Repaid | -83.20K | -135.70K | -172.50K | -172.50K | -57.50K |
| Issuance of Common Stock | -- | 2.42M | 1.41M | 660.00K | 1.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 405.00K | 2.29M | 1.24M | 487.50K | 1.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.03M | 1.38M | 156.90K | -136.20K | -135.70K |